Skip to main content
. 2012 Oct 1;7(10):1133–1141. doi: 10.4161/epi.21915

Table 3. LINE-1 DNA Methylation according to micronutrient status in 568 school-age children from Bogotá, Colombia.

 
LINE-1 DNA Methylation (%5mC)2
 
N1 All
N1 Males
N1 Females
  Mean (SD) %5mC difference (95% CI) Mean (SD) %5mC difference (95% CI) Mean (SD) %5mC difference (95% CI)
Erythrocyte Folate, nmol/L
 
 
 
 
 
 
 
 
 
     Q1
139
80.24 (0.61)
Reference
64
80.32 (0.60)
Reference
75
80.13 (0.59)
Reference
     Q2
139
80.21 (0.64)
-0.03 (-0.18, 0.11)
64
80.31 (0.65)
-0.01 (-0.23, 0.20)
74
80.17 (0.66)
0.04 (-0.16, 0.24)
     Q3
139
80.25 (0.67)
0.01 (-0.14, 0.16)
65
80.41 (0.62)
0.09 (-0.11, 0.30)
75
80.11 (0.69)
-0.02 (-0.23, 0.18)
     Q4
139
80.28 (0.67)
0.04 (-0.11, 0.19)
64
80.46 (0.68)
0.14 (-0.09, 0.36)
75
80.14 (0.63)
0.01 (-0.19, 0.20)
     P trend3
 
0.51
 
 
0.15
 
 
0.90
 
Plasma Vitamin B12, pmol/L
 
 
 
 
 
 
 
 
 
     Q1
137
80.30 (0.64)
Reference
64
80.40 (0.69)
Reference
72
80.19 (0.58)
Reference
     Q2
136
80.26 (0.61)
-0.04 (-0.19, 0.11)
63
80.41 (0.63)
0.01 (-0.22, 0.24)
72
80.13 (0.53)
-0.06 (-0.24, 0.12)
     Q3
134
80.24 (0.66)
-0.06 (-0.22, 0.09)
64
80.38 (0.63)
-0.02 (-0.25, 0.21)
72
80.12 (0.69)
-0.07 (-0.28, 0.14)
     Q4
136
80.18 (0.72)
-0.12 (-0.28, 0.04)
64
80.26 (0.64)
-0.15 (-0.38, 0.08)
72
80.11 (0.78)
-0.07 (-0.30, 0.15)
     P trend3
 
0.15
 
 
0.20
 
 
0.52
 
Serum Zinc, μmol/L
 
 
 
 
 
 
 
 
 
     Q1
140
80.22 (0.66)
Reference
66
80.33 (0.65)
Reference
75
80.13 (0.64)
Reference
     Q2
142
80.23 (0.64)
0.01 (-0.14, 0.16)
65
80.36 (0.65)
0.03 (-0.19, 0.25)
76
80.12 (0.63)
-0.01 (-0.22, 0.19)
     Q3
141
80.30 (0.64)
0.07 (-0.08, 0.23)
65
80.43 (0.62)
0.10 (-0.11, 0.32)
75
80.16 (0.62)
0.03 (-0.17, 0.23)
     Q4
141
80.24 (0.68)
0.02 (-0.14, 0.18)
66
80.36 (0.67)
0.04 (-0.19, 0.26)
76
80.15 (0.69)
0.01 (-0.20, 0.22)
     P trend3
 
0.60
 
 
0.61
 
 
0.82
 
Plasma ferritin, μg/L
 
 
 
 
 
 
 
 
 
     Q1
141
80.34 (0.66)
Reference
66
80.49 (0.65)
Reference
75
80.17 (0.62)
Reference
     Q2
139
80.18 (0.63)
-0.16 (-0.31, -0.01)
66
80.35 (0.63)
-0.14 (-0.35, 0.08)
76
80.10 (0.65)
-0.07 (-0.27, 0.14)
     Q3
143
80.26 (0.64)
-0.08 (-0.24, 0.07)
64
80.31 (0.61)
-0.17 (-0.39, 0.04)
75
80.15 (0.63)
-0.01 (-0.21, 0.19)
     Q4
141
80.21 (0.68)
-0.13 (-0.28, 0.03)
66
80.33 (0.69)
-0.16 (-0.38, 0.07)
76
80.14 (0.69)
-0.02 (-0.23, 0.19)
     P trend4
 
0.22
 
 
0.16
 
 
0.96
 
Plasma vitamin A, μmol/L
 
 
 
 
 
 
 
 
 
     < 0.700
72
80.37 (0.63)
Reference
34
80.40 (0.59)
Reference
38
80.35 (0.67)
Reference
     0.700 - 1.049
235
80.32 (0.63)
-0.06 (-0.22, 0.11)
111
80.45 (0.67)
0.05 (-0.18, 0.29)
124
80.20 (0.57)
-0.16 (-0.39, 0.07)
     ≥ 1.050
260
80.16 (0.67)
-0.22 (-0.38, -0.05)
118
80.29 (0.63)
-0.10 (-0.33, 0.12)
142
80.04 (0.69)
-0.31 (-0.55, -0.07)
     P trend3   0.002     0.13     0.006  

1Totals may be < 568 for all children, < 263 for males, and < 305 for females because of missing values. 2From mixed effects linear regression models where site was a random effect. 3From univariate regression models in which a variable representing the ordinal predictor was introduced as continuous.